Literature DB >> 20012713

Long-term fate of allogeneic neural stem cells following transplantation into injured spinal cord.

Liang Xu1, Chao-jin Xu, He-Zuo Lü, Yan-Xia Wang, Ying Li, Pei-Hua Lu.   

Abstract

To characterize the fate of allogeneic neural stem cells (NSCs) following transplantation into injured spinal cord, green fluorescent protein (GFP)-NSCs isolated from GFP transgenic Sprague-Dawley rat embryos were transplanted into contused spinal cords of Wistar rats. The GFP-NSCs survived for at least 6 months in injured spinal cord; most of them differentiated rapidly into astrocytes, and a few were able to undergo proliferation. After transplantation, the GFP-NSCs remained in the transplantation site at the early stage, and then migrated along white-matter, and gathered around the injured cavity. At 6 months post-transplantation, CD8 T-lymphocytes infiltrated the spinal cord, and mixed lymphocyte culture from host and donor showed that lymphocytes from the host spleen were primed by allogeneic GFP-NSCs. At 12 months post-transplantation, most GFP cells in the spinal cord lost their morphology and disintegrated. The Basso, Beattie and Bresnahan score and footprint analysis indicated that the improvement of locomotor function in transplanted rats appeared only at the early stage, and was not seen even at 6 months after transplantation All these results suggest that the allogeneic NSCs, after transplantation into injured spinal cord, activate the host immune system. Therefore, if immunosuppressive agents are not used, the grafted allogeneic NSCs, although they can survive for a long time, are subjected to host immune rejection, and the effect of NSCs on functional recovery is limited.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20012713     DOI: 10.1007/s12015-009-9104-y

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  49 in total

1.  Neural stem cells protect against glutamate-induced excitotoxicity and promote survival of injured motor neurons through the secretion of neurotrophic factors.

Authors:  Jerònia Lladó; Christine Haenggeli; Nicholas J Maragakis; Evan Y Snyder; Jeffrey D Rothstein
Journal:  Mol Cell Neurosci       Date:  2004-11       Impact factor: 4.314

2.  Lineage-restricted neural precursors survive, migrate, and differentiate following transplantation into the injured adult spinal cord.

Authors:  A C Lepore; I Fischer
Journal:  Exp Neurol       Date:  2005-07       Impact factor: 5.330

3.  Tracking neural stem cells in patients with brain trauma.

Authors:  Jianhong Zhu; Liangfu Zhou; FengGe XingWu
Journal:  N Engl J Med       Date:  2006-11-30       Impact factor: 91.245

Review 4.  Innate immunity and protective neuroinflammation: new emphasis on the role of neuroimmune regulatory proteins.

Authors:  M Griffiths; J W Neal; P Gasque
Journal:  Int Rev Neurobiol       Date:  2007       Impact factor: 3.230

Review 5.  Can the immune system be harnessed to repair the CNS?

Authors:  Phillip G Popovich; Erin E Longbrake
Journal:  Nat Rev Neurosci       Date:  2008-06       Impact factor: 34.870

6.  Paradoxical early immune activation during acceptance of liver allografts compared with rejection of skin grafts in a rat model of transplantation.

Authors:  K L Rokahr; A F Sharland; J Sun; C Wang; A G Sheil; Y Yan; G W McCaughan; G A Bishop
Journal:  Immunology       Date:  1998-10       Impact factor: 7.397

7.  Interleukin-1beta mediates proliferation and differentiation of multipotent neural precursor cells through the activation of SAPK/JNK pathway.

Authors:  Xiaofei Wang; Saili Fu; Yanxia Wang; Panpan Yu; Jianguo Hu; Wenli Gu; Xiao-Ming Xu; Peihua Lu
Journal:  Mol Cell Neurosci       Date:  2007-07-24       Impact factor: 4.314

8.  Engineering angiogenesis following spinal cord injury: a coculture of neural progenitor and endothelial cells in a degradable polymer implant leads to an increase in vessel density and formation of the blood-spinal cord barrier.

Authors:  Millicent Ford Rauch; Sara Royce Hynes; James Bertram; Andy Redmond; Rebecca Robinson; Cicely Williams; Hao Xu; Joseph A Madri; Erin B Lavik
Journal:  Eur J Neurosci       Date:  2009-01       Impact factor: 3.386

9.  Chemokines regulate the migration of neural progenitors to sites of neuroinflammation.

Authors:  Abdelhak Belmadani; Phuong B Tran; Dongjun Ren; Richard J Miller
Journal:  J Neurosci       Date:  2006-03-22       Impact factor: 6.167

Review 10.  Opinion: neural stem cell therapy for neurological diseases: dreams and reality.

Authors:  Ferdinando Rossi; Elena Cattaneo
Journal:  Nat Rev Neurosci       Date:  2002-05       Impact factor: 34.870

View more
  13 in total

1.  Nogo-A-Δ20/EphA4 interaction antagonizes apoptosis of neural stem cells by integrating p38 and JNK MAPK signaling.

Authors:  Jun-Ling Wang; Wei-Guang Chen; Jia-Jia Zhang; Chao-Jin Xu
Journal:  J Mol Histol       Date:  2021-02-08       Impact factor: 2.611

2.  Survival of neural progenitors allografted into the CNS of immunocompetent recipients is highly dependent on transplantation site.

Authors:  M Janowski; C Engels; M Gorelik; A Lyczek; S Bernard; J W M Bulte; P Walczak
Journal:  Cell Transplant       Date:  2013-01-02       Impact factor: 4.064

Review 3.  The Neural Stem Cell Microenvironment: Focusing on Axon Guidance Molecules and Myelin-Associated Factors.

Authors:  Chao-Jin Xu; Jun-Ling Wang; Wei-Lin Jin
Journal:  J Mol Neurosci       Date:  2015-03-11       Impact factor: 3.444

Review 4.  Drugs and Endogenous Factors as Protagonists in Neurogenic Stimulation.

Authors:  Raphaela A Chiareli; Bruno L Marques; Gustavo A de Carvalho; Raysa T V de Souza; Pedro H G Santana; Helton C Santiago; Mauro C X Pinto; Alexander Birbrair; Ricardo C Parreira; Henning Ulrich; Rodrigo R Resende
Journal:  Stem Cell Rev Rep       Date:  2022-08-12       Impact factor: 6.692

5.  MHC mismatch results in neural progenitor cell rejection following spinal cord transplantation in a model of viral-induced demyelination.

Authors:  Jason G Weinger; Brian M Weist; Warren C Plaisted; Suzi M Klaus; Craig M Walsh; Thomas E Lane
Journal:  Stem Cells       Date:  2012-11       Impact factor: 6.277

6.  Activating receptor NKG2D targets RAE-1-expressing allogeneic neural precursor cells in a viral model of multiple sclerosis.

Authors:  Jason G Weinger; Warren C Plaisted; Sonia M Maciejewski; Lewis L Lanier; Craig M Walsh; Thomas E Lane
Journal:  Stem Cells       Date:  2014-10       Impact factor: 6.277

Review 7.  Induced pluripotent stem cells for spinal cord injury therapy: current status and perspective.

Authors:  H Wang; H Fang; J Dai; G Liu; Z J Xu
Journal:  Neurol Sci       Date:  2012-07-15       Impact factor: 3.307

8.  Controlling immune rejection is a fail-safe system against potential tumorigenicity after human iPSC-derived neural stem cell transplantation.

Authors:  Go Itakura; Yoshiomi Kobayashi; Soraya Nishimura; Hiroki Iwai; Morito Takano; Akio Iwanami; Yoshiaki Toyama; Hideyuki Okano; Masaya Nakamura
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

Review 9.  Patient-specific induced pluripotent stem cells in neurological disease modeling: the importance of nonhuman primate models.

Authors:  Zhifang Qiu; Steven L Farnsworth; Anuja Mishra; Peter J Hornsby
Journal:  Stem Cells Cloning       Date:  2013-07-03

Review 10.  Neural stem/progenitor cells in Alzheimer's disease.

Authors:  Gizem Tincer; Violeta Mashkaryan; Prabesh Bhattarai; Caghan Kizil
Journal:  Yale J Biol Med       Date:  2016-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.